EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advancing immunotherapy in small cell lung cancer

Jennifer W Carlisle iD, Ticiana Leal iD

Cancer · 2023

DOI: 10.1002/cncr.34977 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer, 2023. Verfasst von Jennifer W Carlisle und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Lung Neoplasms, Carcinoma, Neuroendocrine. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 82 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small cell lung cancer (SCLC) is a rapidly progressive neuroendocrine carcinoma that, until recently, had a very small armamentarium of effective treatments. Advances in DNA sequencing and whole transcriptomics have delineated key subtypes; therefore, SCLC is no longer viewed as a homogeneous cancer. Chemoimmunotherapy with PD1 blockade is now the standard of care for advanced disease, and ongoing research efforts are moving this strategy into the limited stage setting. Combination strategies of immunotherapy with radiation are also under active clinical trial in both limited and extensive stage disease. Plain Language Summary Small cell lung cancer (SCLC) is a rapidly progressive neuroendocrine carcinoma that, until recently, had a very small armamentarium of effective treatments. Chemoimmunotherapy with immune check point inhibitors is now the standard of care for advanced disease. This comprehensive review provides an overview of current treatment strategies for SCLC, unmet needs in this patient population, and emerging treatment strategies incorporating immunotherapy that will hopefully further improve outcomes for patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Small Cell Lung CarcinomaLung NeoplasmsCarcinoma, NeuroendocrineHumansImmunotherapyTreatment Outcome

Stichwörter der Autor:innen

EGFR transformationbiomarkercheckpoint blockadeimmunotherapysmall cell lung carcinoma

Autor:innen und Institutionen

  • Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Hematology and Medical Oncology, Thoracic Medical Oncology Program, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.

ORCID-Profile: Jennifer W Carlisle, Ticiana Leal

Zitieren

APA

Carlisle, J. W., & Leal, T. (2023). Advancing immunotherapy in small cell lung cancer. Cancer. https://doi.org/10.1002/cncr.34977

Vancouver

Carlisle JW, Leal T. Advancing immunotherapy in small cell lung cancer. Cancer. 2023. doi:10.1002/cncr.34977

BibTeX
@article{Carlisle2023,
  author = {Carlisle, Jennifer W and Leal, Ticiana},
  title = {Advancing immunotherapy in small cell lung cancer},
  journal = {Cancer},
  year = {2023},
  doi = {10.1002/cncr.34977}
}
Kostenlos starten →